Washington University School of Medicine
St Louis, Missouri, 63110, United States
NCT Number: NCT01538823
The purpose of this study is to define early urinary biomarkers for diagnosis and prognosis of Renal Cell Carcinoma (RCC) with subsequent development of reliable, cost-effective, screening techniques.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
St Louis, Missouri, 63110, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 5 years
The overall objective of our study is to find and evaluate additional novel biomarkers, predictive of disease, that are present and measurable in whole urine of patients undergoing surgery for renal cancer.
Washington University School of Medicine
Other
Urine Proteome of Surgical Patients and Healthy Volunteers.
Acronym: UP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03455452
Adenocarcinoma, Adenocarcinoma Of Kidney
Paris, France
View Trial DetailsNCT02684006
Adenocarcinoma, Carcinoma
Daphne, Alabama, United States
View Trial DetailsNCT06829888
Adenocarcinoma, Carcinoma
View Trial DetailsNCT05363072
Adenocarcinoma, Cancer of Kidney
Helsinki, Finland
View Trial Details